文献速递脑血管病

半胱氨酸改变型NOTCH3变异是老年人群卒中危险因素

Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population.
PubMed 文献 · Stroke · 2020-11-09

基于Geisinger DiscovEHR队列92 456名参与者的横断面研究,比较118例携带半胱氨酸改变型NOTCH3变异者与184例年龄性别匹配对照。结果显示65岁后卒中风险显著增加(HR 6.0,95%CI 1.4-26.3),白质病变负荷和腔隙灶更多,但痴呆、轻度认知障碍、偏头痛和抑郁无差异。

要点

  • 65岁以上携带NOTCH3半胱氨酸改变变异者卒中风险显著升高(HR 6.0)。
  • 病例组白质高信号负荷和腔隙灶数量高于对照,但严重CADASIL表型罕见。
  • 痴呆、轻度认知障碍、有先兆偏头痛和抑郁在两组间无显著差异。

核心结论

  • 半胱氨酸改变型NOTCH3变异是老年人群卒中、腔隙灶和白质高信号的重要危险因素。

研究设计与样本

  • 横断面研究,使用Geisinger DiscovEHR队列92 456名参与者的临床、神经影像和全外显子测序数据。
  • 病例组为携带NOTCH3半胱氨酸改变变异的个体(n=118),对照组为年龄性别匹配且无NOTCH3非同义变异的随机个体(n=184)。

主要发现

  • 病例组12.6%有卒中史,对照组4.9%。
  • 65岁后卒中风险显著增加(HR 6.0,95%CI 1.4-26.3)。
  • 痴呆、轻度认知障碍、有先兆偏头痛和抑郁在两组间患病率相同。
  • 符合CADASIL的严重小血管病表型罕见。

关键数值与推荐

  • 卒中风险在65岁后显著增加(HR 6.0,95%CI 1.4-26.3)。
  • 病例组卒中史12.6%,对照组4.9%。
  • 65岁后病例组白质病变负荷和腔隙灶多于对照。

临床怎么用

  • 对老年携带NOTCH3半胱氨酸改变变异者应关注卒中风险,尤其65岁后。
  • 脑MRI白质病变负荷和腔隙灶可作为小血管病评估指标。

局限性

  • 横断面设计,仅部分参与者有脑MRI数据(病例25%,对照24%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Cysteine altering NOTCH3 variants, which have previously been exclusively associated with the rare hereditary small vessel disease cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, have a population frequency of 1:300 worldwide. Using a large population database, and taking genotype as a starting point, we aimed to determine whether individuals harboring a NOTCH3 cysteine altering variant have a higher load of small vessel disease markers on brain magnetic resonance imaging than controls, as well as a higher risk of stroke and cognitive impairment. METHODS: A cross-sectional study using integrated clinical, neuroimaging, and whole-exome sequencing data of 92 456 participants from the Geisinger DiscovEHR initiative cohort. The case group consisted of individuals harboring a NOTCH3 cysteine altering variant (n=118). The control group consisted of randomly selected age- and sex-matched individuals who did not have any nonsynonymous variants in NOTCH3 (n=184). Medical records including brain magnetic resonance imagings were evaluated for clinical and neuroimaging findings associated with small vessel disease. Group comparisons were done using Fisher exact test and ordinal logistic regression models. Risk of stroke was assessed using Cox regression. RESULTS: Of the 118 cases, 39.0% were men, mean age 58.1±16.9 years; 12.6% had a history of stroke, compared with 4.9% of controls. The risk of stroke was significantly increased after age 65 years (hazard ratio, 6.0 [95% CI, 1.4-26.3]). Dementia, mild cognitive impairment, migraine with aura and depression were equally prevalent in cases and controls. Twenty-nine cases (25%) and 45 controls (24%) had an available brain magnetic resonance imaging. After age 65 years, cases had a higher white matter lesion burden and more lacunes. A severe small vessel disease phenotype compatible with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy was rarely seen. CONCLUSIONS: Cysteine altering NOTCH3 variants are an important contributor to the risk of stroke, lacunes, and white matter hyperintensities in the elderly population.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Hack RJ, Rutten JW, Person TN, et al. Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population. Stroke. 2020. PMID: 33161844. doi:10.1161/STROKEAHA.120.030343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。